Journal article icon

Journal article

Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy

Abstract:

Duchenne muscular dystrophy is a rare, progressive, muscle-wasting disease leading to severe disability and premature death. Treatment is currently symptomatic, but several experimental therapies are in development. Implemented care standards, validated outcome measures correlating with clinical benefit, and comprehensive information about the natural history of the disease are essential for regulatory approval of any treatment. However, for Duchenne muscular dystrophy and other rare diseases...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/S1474-4422(16)30035-7

Authors


Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Lancet Neurology Journal website
Volume:
15
Issue:
8
Pages:
882-890
Publication date:
2016-07-01
DOI:
EISSN:
1474-4465
ISSN:
1474-4422
Pmid:
27302365
Source identifiers:
652027
Language:
English
Keywords:
Pubs id:
pubs:652027
UUID:
uuid:022629c9-5c9f-4039-b89f-4b3153c5efee
Local pid:
pubs:652027
Deposit date:
2017-04-20

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP